May Garrett
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Renal cell carcinoma treatment
Papers in
-
- Renal cell carcinoma treatment 7
- Lung Cancer Treatments and Mutations 3
- Oncology 7
- CAR-T cell therapy research 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Yazdi K. Pithavala (11 shared papers)Brian Hee (6 shared papers)Karen J. Klamerus (6 shared papers)Michael A. Tortorici (5 shared papers)Melvin Toh (5 shared papers)Ying Chen (1 shared paper)Olivier Rixe (3 shared papers)Jamal Tarazi (3 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (4 papers)Journal of Clinical Oncology (3 papers)Clinical Pharmacology & Therapeutics (3 papers)Investigational New Drugs (2 papers)Blood (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
May Garrett
24 papers receiving 845 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 104
- Pulmonary and Respiratory Medicine 331
- Hematology 101
- Oncology 236
- Cancer Research 120
Countries citing papers authored by May Garrett
This map shows the geographic impact of May Garrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Garrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Garrett more than expected).
Fields of papers citing papers by May Garrett
This network shows the impact of papers produced by May Garrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Garrett. The network helps show where May Garrett may publish in the future.
Co-authors
The 25 scholars most cited alongside May Garrett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 188 | |
| 2 | 2013 | 117 | |
| 3 | 2013 | 101 | |
| 4 | 2009 | 66 | |
| 5 | 2009 | 60 | |
| 6 | 2010 | 53 | |
| 7 | 2009 | 40 | |
| 8 | 2012 | 36 | |
| 9 | 2010 | 31 | |
| 10 | 2019 | 27 | |
| 11 | 2015 | 23 | |
| 12 | 2013 | 22 | |
| 13 | 2015 | 17 | |
| 14 | 2011 | 16 | |
| 15 | 2010 | 14 | |
| 16 | 2014 | 14 | |
| 17 | 2011 | 9 | |
| 18 | 2017 | 6 | |
| 19 | A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects | 2007 | 6 |
| 20 | 2023 | 5 |
About May Garrett
May Garrett is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Molecular Biology and Pharmacology, having authored 24 papers that have together received 859 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Chronic Myeloid Leukemia Treatments (5 papers), Pharmacogenetics and Drug Metabolism (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Chronic Kidney Disease and Diabetes (2 papers), CAR-T cell therapy research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Pharmacology (104 citations), Pulmonary and Respiratory Medicine (331 citations), Hematology (101 citations), Oncology (236 citations) and Cancer Research (120 citations). May Garrett has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Yazdi K. Pithavala, Brian Hee, Karen J. Klamerus, Michael A. Tortorici, Melvin Toh, Ying Chen, Olivier Rixe, Jamal Tarazi, Janice P. Dutcher and George Wilding. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, Investigational New Drugs and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.